Davol was founded in Providence, RI in 1874. Back then, the company supplied the medical community with hot water bottles and catheters. For the past 40 years, Davol has stood out as the market leader in providing solutions in soft tissue reconstruction solutions including products for hernia repair, specialized surgical procedures, fixation and biologic implants. Now a subsidiary of C.R. Bard, Inc., Davol continues to maintain its leadership position in the medical device industry with an expanded portfolio of proven, innovative solutions. These include a growing line of mesh prosthetics, biologic implants, surgical instruments and techniques for inguinal, ventral and other hernia repair procedures, plus a range of products for autotransfusion, hemostasis, laparoscopy, hysteroscopy, pulsed lavage and wound management. Researchers at Davol are constantly engaged in expanding the range of soft tissue repair, hemostasis and performance irrigation products aimed at providing exceptional reliability and value – qualities that clinicians, physicians and patients have come to depend on from Davol.
| Website | http://www.davol.com/ |
| Revenue | $23 million |
| Employees | 125 (55 on RocketReach) |
| Founded | 1874 |
| Address | 100 Crossings Boulevard, Warwick, Rhode Island 02886, US |
| Phone | +1 800-556-6756 |
| Industry | Medical Equipment Manufacturing, Hernia Repair & Fixation, BioSurgery Sealants & Hemostats, Breast Reconstruction, Open Orthopedics, Laparoscopic Irrigation, Wound Management |
| Web Rank | 11 Million |
| Keywords | Soft Tissue Repair, Medical Devices, Reconstructive Surgery, Tissue Regeneration, Tissue Engineering, Surgical Devices, Regenerative Medicine, Wound Care, Biomedical, Surgical Supplies, Advanced Wound Care, Catheters, Surgical Instruments, Healthcare, Medical Supplies, Medical Technology, Surgical Tools, Health Technology, Medical Equipment, Hospital Supplies |
| Competitors | Medtronic, Stryker, Boston Scientific, Baxter International Inc., Zimmer Biomet, Cook Medical, CR Bard - Europe, Middle East and Africa (EMEA), Ethicon, Inc., Acelity, インテュイティブサージカル(合同) +43 more (view full list) |
Looking for a particular Bard Davol employee's phone or email?
The Bard Davol annual revenue was $23 million in 2026.
Juan de Cardenas is the Director Product Development, Biosurgery Hemostats of Bard Davol.
55 people are employed at Bard Davol.
Bard Davol is based in Warwick, Rhode Island.